IRF5-deficient MRL/lpr mice have greatly reduced numbers of spleen plasmablasts and bone marrow plasma cells.

Abstract

<p>A. Spleen cells from IRF5<sup>+/+</sup> and IRF5<sup>−/−</sup> MRL/lpr mice at 4 months of age were stained with antibodies against CD19, CD3, B220, CD22, CD44 and CD138. Plasmablasts (B220<sup>low</sup>CD22<sup>low</sup>CD44<sup>+</sup>CD138<sup>+</sup>) were identified within the splenic B cell (CD19<sup>+</sup>CD3<sup>−</sup>) population. Bone-marrow cells from IRF5<sup>+/+</sup> and IRF5<sup>−/−</sup> MRL/lpr mice were stained with antibodies against CD4, CD8, F4/80, Gr-1, B220 and CD138. CD4<sup>−</sup>CD8<sup>−</sup>F4/80<sup>−</sup>Gr-1<sup>−</sup> cells were gated to analyze plasma cells (B220<sup>−</sup>CD138<sup>+</sup>). B. Numbers and percentages of spleen plasmablasts and bone marrow plasma cells of IRF5<sup>+/+</sup> (filled circles) and IRF5<sup>−/−</sup> (open circles) MRL/lpr mice at 2, 3 and 4 months of age are shown. Each dot represents an individual mouse. Bars represent mean ± SEM. *p<0.05; **p<0.01.</p

    Similar works

    Full text

    thumbnail-image

    Available Versions